Buntanetap (L-Tartrate) is an orally bioavailable small molecule that inhibits the synthesis of several neurotoxic proteins. It acts by suppressing the translation of APP mRNA, thereby reducing amyloid precursor protein production. This inhibitor is utilized in vitro and in vivo for neurodegenerative disease research, particularly Alzheimer's disease.